ArticleOpen forum infectious diseases2024

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.

Simiso Sokhela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.